Cargando…
Nutritional therapy for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and presents together with cirrhosis in most cases. In addition to commonly recognized risk factors for HCC development, such as hepatitis B virus/hepatitis C virus infection, age and alcohol/tobacco consumption, there are nutr...
Autores principales: | Ruiz-Margáin, Astrid, Román-Calleja, Berenice M, Moreno-Guillén, Paulina, González-Regueiro, José A, Kúsulas-Delint, Deyanira, Campos-Murguía, Alejandro, Flores-García, Nayelli C, Macías-Rodríguez, Ricardo Ulises |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529929/ https://www.ncbi.nlm.nih.gov/pubmed/34721776 http://dx.doi.org/10.4251/wjgo.v13.i10.1440 |
Ejemplares similares
-
Reply to: “Liver fibrosis and adverse outcomes in COVID-19”
por: Ruiz-Margáin, Astrid, et al.
Publicado: (2021) -
Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19
por: Campos-Murguía, Alejandro, et al.
Publicado: (2021) -
Clinical perspectives, assessment, and mechanisms of metabolic-associated fatty liver disease in patients with COVID-19
por: Campos-Murguía, Alejandro, et al.
Publicado: (2021) -
Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
por: Campos-Murguía, Alejandro, et al.
Publicado: (2020) -
Myostatin is associated with the presence and development of acute-on-chronic liver failure
por: Ruiz-Margáin, Astrid, et al.
Publicado: (2023)